Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Alzheimer Disease

The first study to measure vitamin D in the brain could help reveal how to maintain cognitive health

A new study found a link between higher concentrations of Vitamin D and improved cognition in aging people.

Inverse

Commentary: By sharing their genetic risks, Hemsworth, Jolie are raising awareness of testing

When actor Chris Hemsworth, aka Thor, God of Thunder, agreed to host a National Geographic series about extending the human life span, he didn’t expect to discover a genetic risk of his own. But that’s what happened as Hemsworth revealed on an episode of “Limitless” that he carries a common…

Chicago Tribune

Harnessing the brain's immune cells to stave off Alzheimer's and other neurodegenerative diseases

Many neurodegenerative diseases, or conditions that result from the loss of function or death of brain cells, remain largely untreatable. Most available treatments target just one of the multiple processes that can lead to neurodegeneration, which may not be effective in completely addressing disease symptoms or progress, if at all.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Blood test could detect Alzheimer's disease years before symptoms

The new test could detect a toxic protein which has been linked to Alzheimer's disease years before any symptoms appear in the patient

Wales Online

Blood test can detect ‘toxic’ protein years before Alzheimer’s symptoms – study

Currently patients tend to receive a diagnosis of Alzheimer’s only after they show well-known signs of the disease.

The Independent UK

Trial offers new hope for Alzheimer's Disease treatment

Hunter residents at high risk of developing Alzheimer's Disease will be given access to a clinical trial involving a breakthrough drug that appears to slow the development of the disease.

Newcastle Herald

New drug is 'beginning of the end' of Alzheimer's - who will it help and when will it be available?

Lecanemab has been shown in trials to slow the progress of early-stage Alzheimer's by 27%

Wales Online

Read news from The Economist, FT, and more,
with one subscription

Exciting new drug is ‘beginning of the end’ for Alzheimer’s – so what is it and when could it be available?

As trial results bring hope of an effective treatment, Lisa Salmon asks The Alzheimer’s Society what it means for people right now.

The Independent UK

Drug proven to slow decline in Alzheimer patients

Lecanemab, a newly developed drug, has showed promising results in clinical trials among Alzheimer patients

Manchester Evening News

‘Momentous breakthrough’: New Alzheimer’s drug lives up to bold claims, with caveats

Data supports claims that a new drug reduced cognitive and functional decline in Alzheimer's patients by 27 per cent in a clinical trial.

The New Daily

New Alzheimer's drug hailed as 'game-changing' as it's proven to slow disease

The drug slowed the disease progression by 27 percent compared to patients taking the placebo.

Daily Record

Breakthrough Alzheimer's drug hailed as 'beginning of the end' for treating disease

Lecanemab was found to have reduced memory decline by targeting and clearing amyloid, which is one of the proteins that build up in the brains of people with the disease

Daily Mirror

Simple urine test could be used to diagnose early-stage Alzheimer’s disease

The early stage of the disease occurs before the irreversible dementia stage and is the golden window for intervention and treatment

Wales Online

Molecule in urine ‘could be the first to reveal early-stage Alzheimer’s disease’

The findings suggest a simple urine test could be used to identify people who are in the early stages of the disease.

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Wales Online

New Alzheimer’s drug hailed as 'beginning of the end' in quest for treatment

Clinical results suggest that the disease progression can by slowed by 27%

The Independent UK

New Alzheimer’s drug hailed as ‘beginning of the end’ in search for treatment

Lecanemab was found to slow decline in patients’ memory and thinking.

The Conversation

Another Alzheimer’s drug fails in late-stage trials – what now?

Around 55 million people, globally, have dementia – the most common type being Alzheimer’s disease. Unfortunately, there is no cure for the memory-robbing disease. But a lot of hope was pinned on an experimental drug called gantenerumab.

Evening Standard

How likely is Chris Hemsworth to get Alzheimer’s disease and what are its signs?

The actor told Vanity Fair the discovery he is at high risk is his ‘biggest fear’ but said: ‘It’s not like I’ve been handed my resignation’

Get all your
news in one place.

100's of premium titles.
One news app.

ABC News

Chris Hemsworth reveals he inherits Alzheimer's gene from both parents. What is the ApoE4 gene and what does it mean for his career?

After two decades of acting, Chris Hemsworth revealed he will take a break from his career, after learning he has a much higher-than-average chance of developing Alzheimer's disease.

The Times of India

Chris Hemsworth learns he has a predisposition to Alzheimer's disease; may take break from acting

Hollywood actor Chris Hemsworth, who recently featured in the docuseries 'Limitless', has revealed that he has a genetic predisposition to Alzheimer's disease, and therefore may be taking a break from acting.

The Conversation

My work investigating the links between viruses and Alzheimer’s disease was dismissed for years – but now the evidence is building

This article is part of the Insights Uncharted Brain series. There are many competing theories about what causes Alzheimer’s disease. Here, Ruth Itzhaki reflects on a career dedicated to one of the more controversial lines of research.

The Guardian - UK

Disappointment after potential Alzheimer’s drug fails Roche trial

Swiss pharmaceutical firm carried out two identical phase 3 trials of gantenerumab, with about 1,000 volunteers in each

Tribune News Service

Consumer Health: Can music help someone with Alzheimer's disease?

Alzheimer's disease is a progressive disorder that causes brain cells to waste away and die. Alzheimer's disease is the most common cause of dementia, which is a term used to describe a group of symptoms that affect memory, thinking and social abilities severely enough to interfere with daily function.

The Conversation

Does picking your nose really increase your risk of dementia?

Research Checks interrogate newly published studies and how they’re reported in the media. The analysis is undertaken by one or more academics not involved with the study, and reviewed by another, to make sure it’s accurate.

Benzinga

IGC Q2 2023 Revenue Grows 261%, THC Based Drug For Alzheimer's Entering Phase 2 Trials

India Globalization Capital, Inc. (AMEX:IGC) reported its second fiscal quarter 2023 financial results, revealing revenue of $202,000, a 261% increase compared to $56,000 in the same quarter of 2022.

1 … 12 13 14 15

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Washington

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.